Three-year Follow-Up Analysis of First-Line Axicabtagene Ciloleucel for High-Risk Large B-cell Lymphoma: the ZUMA-12 Study.
Blood(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined